nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—CYP2B6—Thiotepa—sarcoma	0.133	0.194	CbGbCtD
Phenytoin—ABCC2—Vincristine—sarcoma	0.0619	0.0901	CbGbCtD
Phenytoin—ABCC2—Etoposide—sarcoma	0.0568	0.0826	CbGbCtD
Phenytoin—CYP3A7—Vincristine—sarcoma	0.0414	0.0602	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0414	0.0602	CbGbCtD
Phenytoin—CYP3A4—Thiotepa—sarcoma	0.0409	0.0595	CbGbCtD
Phenytoin—ABCC2—Doxorubicin—sarcoma	0.0387	0.0563	CbGbCtD
Phenytoin—ABCB1—Dactinomycin—sarcoma	0.0328	0.0477	CbGbCtD
Phenytoin—CYP3A5—Vincristine—sarcoma	0.031	0.0451	CbGbCtD
Phenytoin—ABCB1—Mitoxantrone—sarcoma	0.0293	0.0427	CbGbCtD
Phenytoin—CYP3A5—Etoposide—sarcoma	0.0284	0.0414	CbGbCtD
Phenytoin—CYP2C8—Etoposide—sarcoma	0.0273	0.0398	CbGbCtD
Phenytoin—CYP2B6—Doxorubicin—sarcoma	0.0246	0.0358	CbGbCtD
Phenytoin—ABCB1—Vincristine—sarcoma	0.0202	0.0294	CbGbCtD
Phenytoin—ABCB1—Etoposide—sarcoma	0.0185	0.0269	CbGbCtD
Phenytoin—CYP3A4—Mitoxantrone—sarcoma	0.0176	0.0256	CbGbCtD
Phenytoin—ABCB1—Doxorubicin—sarcoma	0.0126	0.0184	CbGbCtD
Phenytoin—CYP3A4—Vincristine—sarcoma	0.0121	0.0176	CbGbCtD
Phenytoin—CYP3A4—Etoposide—sarcoma	0.0111	0.0161	CbGbCtD
Phenytoin—CYP3A4—Doxorubicin—sarcoma	0.00756	0.011	CbGbCtD
Phenytoin—Confusional state—Etoposide—sarcoma	0.000233	0.000833	CcSEcCtD
Phenytoin—Muscular weakness—Epirubicin—sarcoma	0.000232	0.000831	CcSEcCtD
Phenytoin—Cardiac arrest—Doxorubicin—sarcoma	0.000232	0.000829	CcSEcCtD
Phenytoin—Anaphylactic shock—Etoposide—sarcoma	0.000231	0.000826	CcSEcCtD
Phenytoin—Mood swings—Doxorubicin—sarcoma	0.000231	0.000826	CcSEcCtD
Phenytoin—Asthenia—Thiotepa—sarcoma	0.000231	0.000825	CcSEcCtD
Phenytoin—Infection—Etoposide—sarcoma	0.000229	0.000821	CcSEcCtD
Phenytoin—Ataxia—Doxorubicin—sarcoma	0.000229	0.00082	CcSEcCtD
Phenytoin—Asthenia—Dactinomycin—sarcoma	0.000229	0.000819	CcSEcCtD
Phenytoin—Feeling abnormal—Mitoxantrone—sarcoma	0.000229	0.000818	CcSEcCtD
Phenytoin—Asthma—Epirubicin—sarcoma	0.000228	0.000814	CcSEcCtD
Phenytoin—Influenza—Epirubicin—sarcoma	0.000228	0.000814	CcSEcCtD
Phenytoin—Dysphagia—Epirubicin—sarcoma	0.000228	0.000814	CcSEcCtD
Phenytoin—Pruritus—Thiotepa—sarcoma	0.000227	0.000814	CcSEcCtD
Phenytoin—Dehydration—Doxorubicin—sarcoma	0.000227	0.000811	CcSEcCtD
Phenytoin—Thrombocytopenia—Etoposide—sarcoma	0.000226	0.000809	CcSEcCtD
Phenytoin—Tachycardia—Etoposide—sarcoma	0.000225	0.000806	CcSEcCtD
Phenytoin—Eosinophilia—Epirubicin—sarcoma	0.000225	0.000806	CcSEcCtD
Phenytoin—Body temperature increased—Vincristine—sarcoma	0.000225	0.000806	CcSEcCtD
Phenytoin—Liver function test abnormal—Doxorubicin—sarcoma	0.000225	0.000805	CcSEcCtD
Phenytoin—Hyperhidrosis—Etoposide—sarcoma	0.000223	0.000799	CcSEcCtD
Phenytoin—Abdominal pain upper—Doxorubicin—sarcoma	0.000223	0.000796	CcSEcCtD
Phenytoin—Orthostatic hypotension—Doxorubicin—sarcoma	0.000223	0.000796	CcSEcCtD
Phenytoin—Hypokalaemia—Doxorubicin—sarcoma	0.000222	0.000793	CcSEcCtD
Phenytoin—Urticaria—Mitoxantrone—sarcoma	0.000221	0.000789	CcSEcCtD
Phenytoin—Breast disorder—Doxorubicin—sarcoma	0.00022	0.000788	CcSEcCtD
Phenytoin—Anorexia—Etoposide—sarcoma	0.00022	0.000787	CcSEcCtD
Phenytoin—Diarrhoea—Thiotepa—sarcoma	0.00022	0.000787	CcSEcCtD
Phenytoin—Body temperature increased—Mitoxantrone—sarcoma	0.00022	0.000785	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000219	0.000785	CcSEcCtD
Phenytoin—Bronchitis—Epirubicin—sarcoma	0.000219	0.000783	CcSEcCtD
Phenytoin—Diarrhoea—Dactinomycin—sarcoma	0.000218	0.000781	CcSEcCtD
Phenytoin—Pancytopenia—Epirubicin—sarcoma	0.000216	0.000773	CcSEcCtD
Phenytoin—Hypotension—Etoposide—sarcoma	0.000216	0.000772	CcSEcCtD
Phenytoin—Gastritis—Doxorubicin—sarcoma	0.000216	0.000772	CcSEcCtD
Phenytoin—Muscular weakness—Doxorubicin—sarcoma	0.000215	0.000769	CcSEcCtD
Phenytoin—Dysuria—Epirubicin—sarcoma	0.000213	0.000761	CcSEcCtD
Phenytoin—Dizziness—Thiotepa—sarcoma	0.000213	0.00076	CcSEcCtD
Phenytoin—Influenza—Doxorubicin—sarcoma	0.000211	0.000753	CcSEcCtD
Phenytoin—Dysphagia—Doxorubicin—sarcoma	0.000211	0.000753	CcSEcCtD
Phenytoin—Asthma—Doxorubicin—sarcoma	0.000211	0.000753	CcSEcCtD
Phenytoin—Hypersensitivity—Vincristine—sarcoma	0.00021	0.000751	CcSEcCtD
Phenytoin—Eosinophilia—Doxorubicin—sarcoma	0.000209	0.000746	CcSEcCtD
Phenytoin—Photosensitivity reaction—Epirubicin—sarcoma	0.000208	0.000743	CcSEcCtD
Phenytoin—Paraesthesia—Etoposide—sarcoma	0.000207	0.000742	CcSEcCtD
Phenytoin—Weight decreased—Epirubicin—sarcoma	0.000206	0.000737	CcSEcCtD
Phenytoin—Dyspnoea—Etoposide—sarcoma	0.000206	0.000736	CcSEcCtD
Phenytoin—Hyperglycaemia—Epirubicin—sarcoma	0.000205	0.000735	CcSEcCtD
Phenytoin—Somnolence—Etoposide—sarcoma	0.000205	0.000734	CcSEcCtD
Phenytoin—Hypersensitivity—Mitoxantrone—sarcoma	0.000205	0.000732	CcSEcCtD
Phenytoin—Asthenia—Vincristine—sarcoma	0.000205	0.000732	CcSEcCtD
Phenytoin—Vomiting—Thiotepa—sarcoma	0.000204	0.000731	CcSEcCtD
Phenytoin—Pneumonia—Epirubicin—sarcoma	0.000204	0.00073	CcSEcCtD
Phenytoin—Drowsiness—Epirubicin—sarcoma	0.000203	0.000726	CcSEcCtD
Phenytoin—Vomiting—Dactinomycin—sarcoma	0.000203	0.000726	CcSEcCtD
Phenytoin—Rash—Thiotepa—sarcoma	0.000203	0.000725	CcSEcCtD
Phenytoin—Bronchitis—Doxorubicin—sarcoma	0.000203	0.000725	CcSEcCtD
Phenytoin—Dermatitis—Thiotepa—sarcoma	0.000203	0.000724	CcSEcCtD
Phenytoin—Headache—Thiotepa—sarcoma	0.000201	0.00072	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000201	0.00072	CcSEcCtD
Phenytoin—Rash—Dactinomycin—sarcoma	0.000201	0.00072	CcSEcCtD
Phenytoin—Decreased appetite—Etoposide—sarcoma	0.000201	0.000718	CcSEcCtD
Phenytoin—Pancytopenia—Doxorubicin—sarcoma	0.0002	0.000716	CcSEcCtD
Phenytoin—Renal failure—Epirubicin—sarcoma	0.0002	0.000714	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Etoposide—sarcoma	0.000199	0.000713	CcSEcCtD
Phenytoin—Asthenia—Mitoxantrone—sarcoma	0.000199	0.000713	CcSEcCtD
Phenytoin—Fatigue—Etoposide—sarcoma	0.000199	0.000712	CcSEcCtD
Phenytoin—Constipation—Etoposide—sarcoma	0.000198	0.000706	CcSEcCtD
Phenytoin—Conjunctivitis—Epirubicin—sarcoma	0.000197	0.000706	CcSEcCtD
Phenytoin—Dysuria—Doxorubicin—sarcoma	0.000197	0.000705	CcSEcCtD
Phenytoin—Diarrhoea—Vincristine—sarcoma	0.000195	0.000698	CcSEcCtD
Phenytoin—Sweating—Epirubicin—sarcoma	0.000195	0.000696	CcSEcCtD
Phenytoin—Photosensitivity reaction—Doxorubicin—sarcoma	0.000192	0.000688	CcSEcCtD
Phenytoin—Hepatobiliary disease—Epirubicin—sarcoma	0.000192	0.000687	CcSEcCtD
Phenytoin—Epistaxis—Epirubicin—sarcoma	0.000191	0.000685	CcSEcCtD
Phenytoin—Nausea—Thiotepa—sarcoma	0.000191	0.000683	CcSEcCtD
Phenytoin—Weight decreased—Doxorubicin—sarcoma	0.000191	0.000682	CcSEcCtD
Phenytoin—Sinusitis—Epirubicin—sarcoma	0.00019	0.000681	CcSEcCtD
Phenytoin—Feeling abnormal—Etoposide—sarcoma	0.00019	0.000681	CcSEcCtD
Phenytoin—Hyperglycaemia—Doxorubicin—sarcoma	0.00019	0.00068	CcSEcCtD
Phenytoin—Diarrhoea—Mitoxantrone—sarcoma	0.00019	0.00068	CcSEcCtD
Phenytoin—Nausea—Dactinomycin—sarcoma	0.00019	0.000678	CcSEcCtD
Phenytoin—Agranulocytosis—Epirubicin—sarcoma	0.000189	0.000678	CcSEcCtD
Phenytoin—Pneumonia—Doxorubicin—sarcoma	0.000189	0.000676	CcSEcCtD
Phenytoin—Dizziness—Vincristine—sarcoma	0.000189	0.000674	CcSEcCtD
Phenytoin—Drowsiness—Doxorubicin—sarcoma	0.000188	0.000672	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000186	0.000666	CcSEcCtD
Phenytoin—Bradycardia—Epirubicin—sarcoma	0.000186	0.000664	CcSEcCtD
Phenytoin—Renal failure—Doxorubicin—sarcoma	0.000185	0.00066	CcSEcCtD
Phenytoin—Urticaria—Etoposide—sarcoma	0.000183	0.000656	CcSEcCtD
Phenytoin—Haemoglobin—Epirubicin—sarcoma	0.000183	0.000655	CcSEcCtD
Phenytoin—Rhinitis—Epirubicin—sarcoma	0.000183	0.000653	CcSEcCtD
Phenytoin—Body temperature increased—Etoposide—sarcoma	0.000183	0.000653	CcSEcCtD
Phenytoin—Conjunctivitis—Doxorubicin—sarcoma	0.000183	0.000653	CcSEcCtD
Phenytoin—Haemorrhage—Epirubicin—sarcoma	0.000182	0.000652	CcSEcCtD
Phenytoin—Hypoaesthesia—Epirubicin—sarcoma	0.000181	0.000649	CcSEcCtD
Phenytoin—Vomiting—Vincristine—sarcoma	0.000181	0.000648	CcSEcCtD
Phenytoin—Pharyngitis—Epirubicin—sarcoma	0.000181	0.000647	CcSEcCtD
Phenytoin—Sweating—Doxorubicin—sarcoma	0.00018	0.000644	CcSEcCtD
Phenytoin—Rash—Vincristine—sarcoma	0.00018	0.000643	CcSEcCtD
Phenytoin—Dermatitis—Vincristine—sarcoma	0.00018	0.000642	CcSEcCtD
Phenytoin—Connective tissue disorder—Epirubicin—sarcoma	0.000179	0.00064	CcSEcCtD
Phenytoin—Headache—Vincristine—sarcoma	0.000179	0.000639	CcSEcCtD
Phenytoin—Hepatobiliary disease—Doxorubicin—sarcoma	0.000178	0.000635	CcSEcCtD
Phenytoin—Epistaxis—Doxorubicin—sarcoma	0.000177	0.000634	CcSEcCtD
Phenytoin—Vomiting—Mitoxantrone—sarcoma	0.000177	0.000631	CcSEcCtD
Phenytoin—Sinusitis—Doxorubicin—sarcoma	0.000176	0.00063	CcSEcCtD
Phenytoin—Agranulocytosis—Doxorubicin—sarcoma	0.000175	0.000627	CcSEcCtD
Phenytoin—Rash—Mitoxantrone—sarcoma	0.000175	0.000626	CcSEcCtD
Phenytoin—Dermatitis—Mitoxantrone—sarcoma	0.000175	0.000626	CcSEcCtD
Phenytoin—Headache—Mitoxantrone—sarcoma	0.000174	0.000622	CcSEcCtD
Phenytoin—Erythema multiforme—Epirubicin—sarcoma	0.000172	0.000616	CcSEcCtD
Phenytoin—Bradycardia—Doxorubicin—sarcoma	0.000172	0.000614	CcSEcCtD
Phenytoin—Hypersensitivity—Etoposide—sarcoma	0.00017	0.000609	CcSEcCtD
Phenytoin—Tinnitus—Epirubicin—sarcoma	0.00017	0.000608	CcSEcCtD
Phenytoin—Haemoglobin—Doxorubicin—sarcoma	0.000169	0.000606	CcSEcCtD
Phenytoin—Nausea—Vincristine—sarcoma	0.000169	0.000606	CcSEcCtD
Phenytoin—Rhinitis—Doxorubicin—sarcoma	0.000169	0.000605	CcSEcCtD
Phenytoin—Haemorrhage—Doxorubicin—sarcoma	0.000169	0.000603	CcSEcCtD
Phenytoin—Hypoaesthesia—Doxorubicin—sarcoma	0.000168	0.0006	CcSEcCtD
Phenytoin—Pharyngitis—Doxorubicin—sarcoma	0.000167	0.000599	CcSEcCtD
Phenytoin—Asthenia—Etoposide—sarcoma	0.000166	0.000593	CcSEcCtD
Phenytoin—Connective tissue disorder—Doxorubicin—sarcoma	0.000166	0.000593	CcSEcCtD
Phenytoin—Nausea—Mitoxantrone—sarcoma	0.000165	0.00059	CcSEcCtD
Phenytoin—Immune system disorder—Epirubicin—sarcoma	0.000165	0.000589	CcSEcCtD
Phenytoin—Chills—Epirubicin—sarcoma	0.000164	0.000585	CcSEcCtD
Phenytoin—Pruritus—Etoposide—sarcoma	0.000163	0.000584	CcSEcCtD
Phenytoin—Erythema multiforme—Doxorubicin—sarcoma	0.000159	0.00057	CcSEcCtD
Phenytoin—Diarrhoea—Etoposide—sarcoma	0.000158	0.000565	CcSEcCtD
Phenytoin—Tinnitus—Doxorubicin—sarcoma	0.000157	0.000562	CcSEcCtD
Phenytoin—Flatulence—Epirubicin—sarcoma	0.000156	0.000559	CcSEcCtD
Phenytoin—Tension—Epirubicin—sarcoma	0.000156	0.000557	CcSEcCtD
Phenytoin—Dysgeusia—Epirubicin—sarcoma	0.000155	0.000556	CcSEcCtD
Phenytoin—Nervousness—Epirubicin—sarcoma	0.000154	0.000551	CcSEcCtD
Phenytoin—Back pain—Epirubicin—sarcoma	0.000153	0.000549	CcSEcCtD
Phenytoin—Dizziness—Etoposide—sarcoma	0.000153	0.000546	CcSEcCtD
Phenytoin—Muscle spasms—Epirubicin—sarcoma	0.000153	0.000545	CcSEcCtD
Phenytoin—Immune system disorder—Doxorubicin—sarcoma	0.000152	0.000545	CcSEcCtD
Phenytoin—Chills—Doxorubicin—sarcoma	0.000151	0.000541	CcSEcCtD
Phenytoin—Ill-defined disorder—Epirubicin—sarcoma	0.000147	0.000526	CcSEcCtD
Phenytoin—Vomiting—Etoposide—sarcoma	0.000147	0.000525	CcSEcCtD
Phenytoin—Anaemia—Epirubicin—sarcoma	0.000147	0.000524	CcSEcCtD
Phenytoin—CYP11B1—hematopoietic system—sarcoma	0.000147	0.0744	CbGeAlD
Phenytoin—Agitation—Epirubicin—sarcoma	0.000146	0.000521	CcSEcCtD
Phenytoin—Rash—Etoposide—sarcoma	0.000146	0.000521	CcSEcCtD
Phenytoin—Dermatitis—Etoposide—sarcoma	0.000145	0.00052	CcSEcCtD
Phenytoin—Headache—Etoposide—sarcoma	0.000145	0.000518	CcSEcCtD
Phenytoin—Flatulence—Doxorubicin—sarcoma	0.000145	0.000517	CcSEcCtD
Phenytoin—Tension—Doxorubicin—sarcoma	0.000144	0.000515	CcSEcCtD
Phenytoin—Dysgeusia—Doxorubicin—sarcoma	0.000144	0.000514	CcSEcCtD
Phenytoin—Malaise—Epirubicin—sarcoma	0.000143	0.000512	CcSEcCtD
Phenytoin—Nervousness—Doxorubicin—sarcoma	0.000143	0.00051	CcSEcCtD
Phenytoin—Vertigo—Epirubicin—sarcoma	0.000143	0.00051	CcSEcCtD
Phenytoin—Syncope—Epirubicin—sarcoma	0.000142	0.000509	CcSEcCtD
Phenytoin—Leukopenia—Epirubicin—sarcoma	0.000142	0.000508	CcSEcCtD
Phenytoin—Back pain—Doxorubicin—sarcoma	0.000142	0.000508	CcSEcCtD
Phenytoin—Muscle spasms—Doxorubicin—sarcoma	0.000141	0.000505	CcSEcCtD
Phenytoin—Palpitations—Epirubicin—sarcoma	0.00014	0.000501	CcSEcCtD
Phenytoin—Loss of consciousness—Epirubicin—sarcoma	0.000139	0.000499	CcSEcCtD
Phenytoin—Cough—Epirubicin—sarcoma	0.000138	0.000495	CcSEcCtD
Phenytoin—Convulsion—Epirubicin—sarcoma	0.000137	0.000492	CcSEcCtD
Phenytoin—Nausea—Etoposide—sarcoma	0.000137	0.000491	CcSEcCtD
Phenytoin—Hypertension—Epirubicin—sarcoma	0.000137	0.00049	CcSEcCtD
Phenytoin—Ill-defined disorder—Doxorubicin—sarcoma	0.000136	0.000487	CcSEcCtD
Phenytoin—Anaemia—Doxorubicin—sarcoma	0.000136	0.000485	CcSEcCtD
Phenytoin—Myalgia—Epirubicin—sarcoma	0.000135	0.000483	CcSEcCtD
Phenytoin—Arthralgia—Epirubicin—sarcoma	0.000135	0.000483	CcSEcCtD
Phenytoin—Chest pain—Epirubicin—sarcoma	0.000135	0.000483	CcSEcCtD
Phenytoin—Agitation—Doxorubicin—sarcoma	0.000135	0.000482	CcSEcCtD
Phenytoin—Discomfort—Epirubicin—sarcoma	0.000133	0.000477	CcSEcCtD
Phenytoin—Malaise—Doxorubicin—sarcoma	0.000132	0.000473	CcSEcCtD
Phenytoin—Dry mouth—Epirubicin—sarcoma	0.000132	0.000472	CcSEcCtD
Phenytoin—Vertigo—Doxorubicin—sarcoma	0.000132	0.000472	CcSEcCtD
Phenytoin—Syncope—Doxorubicin—sarcoma	0.000132	0.000471	CcSEcCtD
Phenytoin—Leukopenia—Doxorubicin—sarcoma	0.000131	0.00047	CcSEcCtD
Phenytoin—Confusional state—Epirubicin—sarcoma	0.000131	0.000467	CcSEcCtD
Phenytoin—Palpitations—Doxorubicin—sarcoma	0.00013	0.000464	CcSEcCtD
Phenytoin—Anaphylactic shock—Epirubicin—sarcoma	0.000129	0.000463	CcSEcCtD
Phenytoin—Loss of consciousness—Doxorubicin—sarcoma	0.000129	0.000461	CcSEcCtD
Phenytoin—Infection—Epirubicin—sarcoma	0.000129	0.00046	CcSEcCtD
Phenytoin—Cough—Doxorubicin—sarcoma	0.000128	0.000458	CcSEcCtD
Phenytoin—Shock—Epirubicin—sarcoma	0.000127	0.000456	CcSEcCtD
Phenytoin—Convulsion—Doxorubicin—sarcoma	0.000127	0.000455	CcSEcCtD
Phenytoin—Nervous system disorder—Epirubicin—sarcoma	0.000127	0.000454	CcSEcCtD
Phenytoin—Thrombocytopenia—Epirubicin—sarcoma	0.000127	0.000453	CcSEcCtD
Phenytoin—Hypertension—Doxorubicin—sarcoma	0.000127	0.000453	CcSEcCtD
Phenytoin—Tachycardia—Epirubicin—sarcoma	0.000126	0.000452	CcSEcCtD
Phenytoin—CYP11B1—Corticotropin-releasing hormone—IL2—sarcoma	0.000126	0.00404	CbGpPWpGaD
Phenytoin—Hyperhidrosis—Epirubicin—sarcoma	0.000125	0.000448	CcSEcCtD
Phenytoin—Myalgia—Doxorubicin—sarcoma	0.000125	0.000447	CcSEcCtD
Phenytoin—Chest pain—Doxorubicin—sarcoma	0.000125	0.000447	CcSEcCtD
Phenytoin—Arthralgia—Doxorubicin—sarcoma	0.000125	0.000447	CcSEcCtD
Phenytoin—Discomfort—Doxorubicin—sarcoma	0.000123	0.000442	CcSEcCtD
Phenytoin—Anorexia—Epirubicin—sarcoma	0.000123	0.000441	CcSEcCtD
Phenytoin—ALB—Selenium Micronutrient Network—HBA1—sarcoma	0.000123	0.00395	CbGpPWpGaD
Phenytoin—SCN1A—L1CAM interactions—SRC—sarcoma	0.000123	0.00394	CbGpPWpGaD
Phenytoin—Dry mouth—Doxorubicin—sarcoma	0.000122	0.000437	CcSEcCtD
Phenytoin—CYP11B1—Corticotropin-releasing hormone—CTNNB1—sarcoma	0.000122	0.0039	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—EZR—sarcoma	0.000122	0.0039	CbGpPWpGaD
Phenytoin—SCN9A—L1CAM interactions—EGFR—sarcoma	0.000122	0.0039	CbGpPWpGaD
Phenytoin—Hypotension—Epirubicin—sarcoma	0.000121	0.000433	CcSEcCtD
Phenytoin—Confusional state—Doxorubicin—sarcoma	0.000121	0.000432	CcSEcCtD
Phenytoin—Anaphylactic shock—Doxorubicin—sarcoma	0.00012	0.000428	CcSEcCtD
Phenytoin—Infection—Doxorubicin—sarcoma	0.000119	0.000426	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000118	0.000422	CcSEcCtD
Phenytoin—Shock—Doxorubicin—sarcoma	0.000118	0.000422	CcSEcCtD
Phenytoin—Nervous system disorder—Doxorubicin—sarcoma	0.000117	0.00042	CcSEcCtD
Phenytoin—Thrombocytopenia—Doxorubicin—sarcoma	0.000117	0.00042	CcSEcCtD
Phenytoin—Insomnia—Epirubicin—sarcoma	0.000117	0.000419	CcSEcCtD
Phenytoin—Tachycardia—Doxorubicin—sarcoma	0.000117	0.000418	CcSEcCtD
Phenytoin—SCN3A—L1CAM interactions—EGFR—sarcoma	0.000116	0.00373	CbGpPWpGaD
Phenytoin—Paraesthesia—Epirubicin—sarcoma	0.000116	0.000416	CcSEcCtD
Phenytoin—Hyperhidrosis—Doxorubicin—sarcoma	0.000116	0.000414	CcSEcCtD
Phenytoin—Dyspnoea—Epirubicin—sarcoma	0.000115	0.000413	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—PTPRC—sarcoma	0.000115	0.00369	CbGpPWpGaD
Phenytoin—Somnolence—Epirubicin—sarcoma	0.000115	0.000412	CcSEcCtD
Phenytoin—SCN8A—Axon guidance—KDR—sarcoma	0.000115	0.00367	CbGpPWpGaD
Phenytoin—Anorexia—Doxorubicin—sarcoma	0.000114	0.000408	CcSEcCtD
Phenytoin—Dyspepsia—Epirubicin—sarcoma	0.000114	0.000408	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—PLCG1—sarcoma	0.000113	0.00361	CbGpPWpGaD
Phenytoin—Decreased appetite—Epirubicin—sarcoma	0.000113	0.000403	CcSEcCtD
Phenytoin—Hypotension—Doxorubicin—sarcoma	0.000112	0.0004	CcSEcCtD
Phenytoin—SCN4A—L1CAM interactions—EGFR—sarcoma	0.000112	0.00358	CbGpPWpGaD
Phenytoin—SCN2A—L1CAM interactions—EGFR—sarcoma	0.000112	0.00358	CbGpPWpGaD
Phenytoin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000112	0.0004	CcSEcCtD
Phenytoin—Fatigue—Epirubicin—sarcoma	0.000112	0.000399	CcSEcCtD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000112	0.00357	CbGpPWpGaD
Phenytoin—Constipation—Epirubicin—sarcoma	0.000111	0.000396	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—PTPRC—sarcoma	0.00011	0.00353	CbGpPWpGaD
Phenytoin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000109	0.00039	CcSEcCtD
Phenytoin—Insomnia—Doxorubicin—sarcoma	0.000108	0.000388	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—PLCG1—sarcoma	0.000108	0.00345	CbGpPWpGaD
Phenytoin—SCN1A—L1CAM interactions—EGFR—sarcoma	0.000108	0.00345	CbGpPWpGaD
Phenytoin—Paraesthesia—Doxorubicin—sarcoma	0.000108	0.000385	CcSEcCtD
Phenytoin—Dyspnoea—Doxorubicin—sarcoma	0.000107	0.000382	CcSEcCtD
Phenytoin—Feeling abnormal—Epirubicin—sarcoma	0.000107	0.000382	CcSEcCtD
Phenytoin—Somnolence—Doxorubicin—sarcoma	0.000106	0.000381	CcSEcCtD
Phenytoin—SCN2A—Developmental Biology—PTPRC—sarcoma	0.000106	0.00339	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—PTPRC—sarcoma	0.000106	0.00339	CbGpPWpGaD
Phenytoin—Dyspepsia—Doxorubicin—sarcoma	0.000105	0.000377	CcSEcCtD
Phenytoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000104	0.00334	CbGpPWpGaD
Phenytoin—Decreased appetite—Doxorubicin—sarcoma	0.000104	0.000372	CcSEcCtD
Phenytoin—SCN4A—Developmental Biology—PLCG1—sarcoma	0.000104	0.00332	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—PLCG1—sarcoma	0.000104	0.00332	CbGpPWpGaD
Phenytoin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000103	0.00037	CcSEcCtD
Phenytoin—Fatigue—Doxorubicin—sarcoma	0.000103	0.000369	CcSEcCtD
Phenytoin—Urticaria—Epirubicin—sarcoma	0.000103	0.000368	CcSEcCtD
Phenytoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000103	0.00329	CbGpPWpGaD
Phenytoin—Constipation—Doxorubicin—sarcoma	0.000102	0.000366	CcSEcCtD
Phenytoin—Body temperature increased—Epirubicin—sarcoma	0.000102	0.000366	CcSEcCtD
Phenytoin—SCN1A—Developmental Biology—PTPRC—sarcoma	0.000102	0.00327	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—PTPRC—sarcoma	0.000101	0.00322	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—CREB1—sarcoma	0.000101	0.00322	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—PLCG1—sarcoma	9.99e-05	0.0032	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—MYOD1—sarcoma	9.93e-05	0.00318	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—FOXO1—sarcoma	9.89e-05	0.00317	CbGpPWpGaD
Phenytoin—Feeling abnormal—Doxorubicin—sarcoma	9.87e-05	0.000353	CcSEcCtD
Phenytoin—SCN5A—Axon guidance—PLCG1—sarcoma	9.84e-05	0.00315	CbGpPWpGaD
Phenytoin—Hypersensitivity—Epirubicin—sarcoma	9.54e-05	0.000341	CcSEcCtD
Phenytoin—Urticaria—Doxorubicin—sarcoma	9.52e-05	0.00034	CcSEcCtD
Phenytoin—Body temperature increased—Doxorubicin—sarcoma	9.47e-05	0.000339	CcSEcCtD
Phenytoin—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	9.44e-05	0.00302	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—MMP2—sarcoma	9.36e-05	0.003	CbGpPWpGaD
Phenytoin—Asthenia—Epirubicin—sarcoma	9.29e-05	0.000332	CcSEcCtD
Phenytoin—SCN9A—Axon guidance—KDR—sarcoma	9.27e-05	0.00297	CbGpPWpGaD
Phenytoin—Pruritus—Epirubicin—sarcoma	9.16e-05	0.000328	CcSEcCtD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—CREB1—sarcoma	9.09e-05	0.00291	CbGpPWpGaD
Phenytoin—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	9.06e-05	0.0029	CbGpPWpGaD
Phenytoin—ALB—mammary gland—sarcoma	9.05e-05	0.0459	CbGeAlD
Phenytoin—SCN3A—Axon guidance—KDR—sarcoma	8.87e-05	0.00284	CbGpPWpGaD
Phenytoin—Diarrhoea—Epirubicin—sarcoma	8.86e-05	0.000317	CcSEcCtD
Phenytoin—Hypersensitivity—Doxorubicin—sarcoma	8.83e-05	0.000316	CcSEcCtD
Phenytoin—SCN5A—L1CAM interactions—SRC—sarcoma	8.65e-05	0.00277	CbGpPWpGaD
Phenytoin—Asthenia—Doxorubicin—sarcoma	8.6e-05	0.000307	CcSEcCtD
Phenytoin—Dizziness—Epirubicin—sarcoma	8.56e-05	0.000306	CcSEcCtD
Phenytoin—SCN4A—Axon guidance—KDR—sarcoma	8.52e-05	0.00273	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—KDR—sarcoma	8.52e-05	0.00273	CbGpPWpGaD
Phenytoin—Pruritus—Doxorubicin—sarcoma	8.48e-05	0.000303	CcSEcCtD
Phenytoin—Vomiting—Epirubicin—sarcoma	8.23e-05	0.000294	CcSEcCtD
Phenytoin—SCN1A—Axon guidance—KDR—sarcoma	8.22e-05	0.00263	CbGpPWpGaD
Phenytoin—Diarrhoea—Doxorubicin—sarcoma	8.2e-05	0.000293	CcSEcCtD
Phenytoin—SCN8A—Developmental Biology—KDR—sarcoma	8.18e-05	0.00262	CbGpPWpGaD
Phenytoin—Rash—Epirubicin—sarcoma	8.16e-05	0.000292	CcSEcCtD
Phenytoin—Dermatitis—Epirubicin—sarcoma	8.16e-05	0.000292	CcSEcCtD
Phenytoin—SCN9A—Axon guidance—CREB1—sarcoma	8.13e-05	0.0026	CbGpPWpGaD
Phenytoin—Headache—Epirubicin—sarcoma	8.11e-05	0.00029	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—FOXO1—sarcoma	8e-05	0.00256	CbGpPWpGaD
Phenytoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	7.97e-05	0.00255	CbGpPWpGaD
Phenytoin—Dizziness—Doxorubicin—sarcoma	7.92e-05	0.000283	CcSEcCtD
Phenytoin—SCN2A—hematopoietic system—sarcoma	7.86e-05	0.0399	CbGeAlD
Phenytoin—SCN3A—Axon guidance—CREB1—sarcoma	7.78e-05	0.00249	CbGpPWpGaD
Phenytoin—Nausea—Epirubicin—sarcoma	7.69e-05	0.000275	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—FOXO1—sarcoma	7.65e-05	0.00245	CbGpPWpGaD
Phenytoin—Vomiting—Doxorubicin—sarcoma	7.62e-05	0.000272	CcSEcCtD
Phenytoin—SCN5A—L1CAM interactions—EGFR—sarcoma	7.58e-05	0.00243	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—MMP2—sarcoma	7.57e-05	0.00242	CbGpPWpGaD
Phenytoin—Rash—Doxorubicin—sarcoma	7.55e-05	0.00027	CcSEcCtD
Phenytoin—Dermatitis—Doxorubicin—sarcoma	7.55e-05	0.00027	CcSEcCtD
Phenytoin—Headache—Doxorubicin—sarcoma	7.5e-05	0.000268	CcSEcCtD
Phenytoin—SCN2A—Axon guidance—CREB1—sarcoma	7.47e-05	0.00239	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—CREB1—sarcoma	7.47e-05	0.00239	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—FOXO1—sarcoma	7.35e-05	0.00235	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—FOXO1—sarcoma	7.35e-05	0.00235	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—MMP2—sarcoma	7.24e-05	0.00232	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—CREB1—sarcoma	7.21e-05	0.00231	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—PTPRC—sarcoma	7.18e-05	0.0023	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—CREB1—sarcoma	7.17e-05	0.0023	CbGpPWpGaD
Phenytoin—Nausea—Doxorubicin—sarcoma	7.12e-05	0.000255	CcSEcCtD
Phenytoin—SCN1A—Developmental Biology—FOXO1—sarcoma	7.09e-05	0.00227	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—PLCG1—sarcoma	7.02e-05	0.00225	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—PDGFRA—sarcoma	7.01e-05	0.00225	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—MMP2—sarcoma	6.96e-05	0.00223	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—MMP2—sarcoma	6.96e-05	0.00223	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—MMP2—sarcoma	6.71e-05	0.00215	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—MMP2—sarcoma	6.68e-05	0.00214	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—KDR—sarcoma	6.62e-05	0.00212	CbGpPWpGaD
Phenytoin—SCN9A—tendon—sarcoma	6.59e-05	0.0334	CbGeAlD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—JUN—sarcoma	6.54e-05	0.00209	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	6.52e-05	0.00209	CbGpPWpGaD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	6.49e-05	0.00208	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—SRC—sarcoma	6.49e-05	0.00208	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—VEGFC—sarcoma	6.42e-05	0.00205	CbGpPWpGaD
Phenytoin—CYP2C8—mammary gland—sarcoma	6.36e-05	0.0323	CbGeAlD
Phenytoin—SCN3A—Developmental Biology—KDR—sarcoma	6.33e-05	0.00203	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—VEGFA—sarcoma	6.32e-05	0.00202	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—NRAS—sarcoma	6.24e-05	0.002	CbGpPWpGaD
Phenytoin—SCN8A—testis—sarcoma	6.21e-05	0.0315	CbGeAlD
Phenytoin—SCN4A—Developmental Biology—KDR—sarcoma	6.08e-05	0.00195	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—KDR—sarcoma	6.08e-05	0.00195	CbGpPWpGaD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	5.98e-05	0.00191	CbGpPWpGaD
Phenytoin—SCN4A—tendon—sarcoma	5.88e-05	0.0298	CbGeAlD
Phenytoin—SCN1A—Developmental Biology—KDR—sarcoma	5.86e-05	0.00188	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—CREB1—sarcoma	5.8e-05	0.00186	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—KDR—sarcoma	5.78e-05	0.00185	CbGpPWpGaD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—VEGFA—sarcoma	5.71e-05	0.00183	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—EGFR—sarcoma	5.68e-05	0.00182	CbGpPWpGaD
Phenytoin—CYP2C9—mammary gland—sarcoma	5.65e-05	0.0287	CbGeAlD
Phenytoin—SCN3A—Developmental Biology—CREB1—sarcoma	5.55e-05	0.00178	CbGpPWpGaD
Phenytoin—SCN9A—testis—sarcoma	5.46e-05	0.0277	CbGeAlD
Phenytoin—CYP2C18—liver—sarcoma	5.41e-05	0.0275	CbGeAlD
Phenytoin—SCN9A—Developmental Biology—MMP2—sarcoma	5.4e-05	0.00173	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—KRAS—sarcoma	5.37e-05	0.00172	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—CREB1—sarcoma	5.33e-05	0.00171	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—CREB1—sarcoma	5.33e-05	0.00171	CbGpPWpGaD
Phenytoin—SLCO1C1—testis—sarcoma	5.3e-05	0.0269	CbGeAlD
Phenytoin—SCN9A—Axon guidance—SRC—sarcoma	5.25e-05	0.00168	CbGpPWpGaD
Phenytoin—SCN5A—cardiac atrium—sarcoma	5.23e-05	0.0265	CbGeAlD
Phenytoin—SCN3A—Developmental Biology—MMP2—sarcoma	5.17e-05	0.00165	CbGpPWpGaD
Phenytoin—CYP3A7—liver—sarcoma	5.15e-05	0.0261	CbGeAlD
Phenytoin—SCN1A—Developmental Biology—CREB1—sarcoma	5.14e-05	0.00165	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—CTNNB1—sarcoma	5.12e-05	0.00164	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—VEGFA—sarcoma	5.11e-05	0.00164	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—CREB1—sarcoma	5.07e-05	0.00162	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—NRAS—sarcoma	5.05e-05	0.00162	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—IL2—sarcoma	5.04e-05	0.00161	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—SRC—sarcoma	5.02e-05	0.00161	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—FOXO1—sarcoma	4.98e-05	0.0016	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—MMP2—sarcoma	4.96e-05	0.00159	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—MMP2—sarcoma	4.96e-05	0.00159	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—VEGFA—sarcoma	4.89e-05	0.00156	CbGpPWpGaD
Phenytoin—SCN4A—testis—sarcoma	4.87e-05	0.0247	CbGeAlD
Phenytoin—SCN3A—Axon guidance—NRAS—sarcoma	4.83e-05	0.00155	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—SRC—sarcoma	4.82e-05	0.00154	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—SRC—sarcoma	4.82e-05	0.00154	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—MMP2—sarcoma	4.79e-05	0.00153	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—MMP2—sarcoma	4.72e-05	0.00151	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—VEGFA—sarcoma	4.69e-05	0.0015	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—VEGFA—sarcoma	4.69e-05	0.0015	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—SRC—sarcoma	4.65e-05	0.00149	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—NRAS—sarcoma	4.64e-05	0.00148	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—NRAS—sarcoma	4.64e-05	0.00148	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—SRC—sarcoma	4.63e-05	0.00148	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—EGFR—sarcoma	4.6e-05	0.00147	CbGpPWpGaD
Phenytoin—SCN3A—tendon—sarcoma	4.57e-05	0.0232	CbGeAlD
Phenytoin—SCN8A—Axon guidance—HRAS—sarcoma	4.56e-05	0.00146	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—VEGFA—sarcoma	4.53e-05	0.00145	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—VEGFA—sarcoma	4.51e-05	0.00144	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TEK—sarcoma	4.51e-05	0.00144	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—NRAS—sarcoma	4.47e-05	0.00143	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—NRAS—sarcoma	4.45e-05	0.00143	CbGpPWpGaD
Phenytoin—CYP2C19—hematopoietic system—sarcoma	4.44e-05	0.0225	CbGeAlD
Phenytoin—SCN3A—bone marrow—sarcoma	4.43e-05	0.0225	CbGeAlD
Phenytoin—SCN3A—Axon guidance—EGFR—sarcoma	4.4e-05	0.00141	CbGpPWpGaD
Phenytoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	4.39e-05	0.0014	CbGpPWpGaD
Phenytoin—CYP3A7-CYP3A51P—liver—sarcoma	4.38e-05	0.0222	CbGeAlD
Phenytoin—SCN9A—Axon guidance—KRAS—sarcoma	4.34e-05	0.00139	CbGpPWpGaD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	4.3e-05	0.00138	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—EGFR—sarcoma	4.23e-05	0.00135	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—EGFR—sarcoma	4.23e-05	0.00135	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—KRAS—sarcoma	4.15e-05	0.00133	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—CTNNB1—sarcoma	4.14e-05	0.00133	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—KDR—sarcoma	4.12e-05	0.00132	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—ANGPT2—sarcoma	4.12e-05	0.00132	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—EGFR—sarcoma	4.07e-05	0.0013	CbGpPWpGaD
Phenytoin—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	4.07e-05	0.0013	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—EGFR—sarcoma	4.06e-05	0.0013	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—ENO2—sarcoma	4.05e-05	0.0013	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—HBA1—sarcoma	4.03e-05	0.00129	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—KRAS—sarcoma	3.99e-05	0.00128	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—KRAS—sarcoma	3.99e-05	0.00128	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—CTNNB1—sarcoma	3.96e-05	0.00127	CbGpPWpGaD
Phenytoin—SCN9A—lymph node—sarcoma	3.95e-05	0.0201	CbGeAlD
Phenytoin—CYP2C8—hematopoietic system—sarcoma	3.87e-05	0.0197	CbGeAlD
Phenytoin—SCN1A—Axon guidance—KRAS—sarcoma	3.85e-05	0.00123	CbGpPWpGaD
Phenytoin—SLCO1C1—lymph node—sarcoma	3.84e-05	0.0195	CbGeAlD
Phenytoin—SCN8A—Developmental Biology—KRAS—sarcoma	3.83e-05	0.00123	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—IL2—sarcoma	3.83e-05	0.00123	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—CTNNB1—sarcoma	3.81e-05	0.00122	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—CTNNB1—sarcoma	3.81e-05	0.00122	CbGpPWpGaD
Phenytoin—SCN3A—testis—sarcoma	3.79e-05	0.0192	CbGeAlD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	3.76e-05	0.0012	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—SRC—sarcoma	3.74e-05	0.0012	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—HRAS—sarcoma	3.69e-05	0.00118	CbGpPWpGaD
Phenytoin—ALB—Platelet degranulation—VEGFA—sarcoma	3.68e-05	0.00118	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—CTNNB1—sarcoma	3.67e-05	0.00117	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—VEGFA—sarcoma	3.65e-05	0.00117	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—CREB1—sarcoma	3.61e-05	0.00116	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—NRAS—sarcoma	3.6e-05	0.00115	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—SRC—sarcoma	3.58e-05	0.00115	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—HRAS—sarcoma	3.53e-05	0.00113	CbGpPWpGaD
Phenytoin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	3.5e-05	0.00112	CbGpPWpGaD
Phenytoin—CYP3A5—hematopoietic system—sarcoma	3.5e-05	0.0178	CbGeAlD
Phenytoin—SCN3A—Developmental Biology—VEGFA—sarcoma	3.49e-05	0.00112	CbGpPWpGaD
Phenytoin—CYP2B6—hematopoietic system—sarcoma	3.48e-05	0.0176	CbGeAlD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	3.46e-05	0.00111	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—NRAS—sarcoma	3.44e-05	0.0011	CbGpPWpGaD
Phenytoin—CYP2C9—hematopoietic system—sarcoma	3.44e-05	0.0175	CbGeAlD
Phenytoin—SCN2A—Developmental Biology—SRC—sarcoma	3.44e-05	0.0011	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—SRC—sarcoma	3.44e-05	0.0011	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PLCG1—sarcoma	3.44e-05	0.0011	CbGpPWpGaD
Phenytoin—ABCC2—tendon—sarcoma	3.42e-05	0.0174	CbGeAlD
Phenytoin—SCN2A—Axon guidance—HRAS—sarcoma	3.39e-05	0.00109	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—HRAS—sarcoma	3.39e-05	0.00109	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—MMP2—sarcoma	3.37e-05	0.00108	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—VEGFA—sarcoma	3.35e-05	0.00107	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—VEGFA—sarcoma	3.35e-05	0.00107	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—SRC—sarcoma	3.32e-05	0.00106	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—NRAS—sarcoma	3.31e-05	0.00106	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—NRAS—sarcoma	3.31e-05	0.00106	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—VEGFC—sarcoma	3.31e-05	0.00106	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—EGFR—sarcoma	3.28e-05	0.00105	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—HRAS—sarcoma	3.27e-05	0.00105	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—SRC—sarcoma	3.27e-05	0.00105	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—HRAS—sarcoma	3.26e-05	0.00104	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—VEGFA—sarcoma	3.25e-05	0.00104	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—TP53—sarcoma	3.24e-05	0.00104	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—VEGFA—sarcoma	3.23e-05	0.00103	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—NRAS—sarcoma	3.19e-05	0.00102	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—VEGFA—sarcoma	3.18e-05	0.00102	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—NRAS—sarcoma	3.14e-05	0.00101	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—EGFR—sarcoma	3.14e-05	0.001	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—KRAS—sarcoma	3.1e-05	0.000992	CbGpPWpGaD
Phenytoin—CYP2B6—skin of body—sarcoma	3.02e-05	0.0153	CbGeAlD
Phenytoin—ALB—testis—sarcoma	3.02e-05	0.0153	CbGeAlD
Phenytoin—SCN4A—Developmental Biology—EGFR—sarcoma	3.01e-05	0.000965	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—EGFR—sarcoma	3.01e-05	0.000965	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—ENO2—sarcoma	3e-05	0.000961	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—HBA1—sarcoma	2.98e-05	0.000955	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—KRAS—sarcoma	2.96e-05	0.000949	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—EGFR—sarcoma	2.91e-05	0.000931	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—EGFR—sarcoma	2.86e-05	0.000917	CbGpPWpGaD
Phenytoin—ALB—liver—sarcoma	2.86e-05	0.0145	CbGeAlD
Phenytoin—SCN2A—Developmental Biology—KRAS—sarcoma	2.85e-05	0.000912	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—KRAS—sarcoma	2.85e-05	0.000912	CbGpPWpGaD
Phenytoin—ABCC2—testis—sarcoma	2.83e-05	0.0144	CbGeAlD
Phenytoin—SCN1A—Developmental Biology—KRAS—sarcoma	2.75e-05	0.000879	CbGpPWpGaD
Phenytoin—SCN3A—lymph node—sarcoma	2.74e-05	0.0139	CbGeAlD
Phenytoin—SCN5A—Axon guidance—KRAS—sarcoma	2.71e-05	0.000866	CbGpPWpGaD
Phenytoin—ABCC2—liver—sarcoma	2.68e-05	0.0136	CbGeAlD
Phenytoin—SCN9A—Developmental Biology—HRAS—sarcoma	2.63e-05	0.000843	CbGpPWpGaD
Phenytoin—CYP3A4—hematopoietic system—sarcoma	2.62e-05	0.0133	CbGeAlD
Phenytoin—ALB—Hemostasis—PLCG1—sarcoma	2.6e-05	0.000832	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—CTNNB1—sarcoma	2.58e-05	0.000826	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.55e-05	0.000818	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PLCG1—sarcoma	2.55e-05	0.000815	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—HRAS—sarcoma	2.52e-05	0.000807	CbGpPWpGaD
Phenytoin—CYP2B6—lymphoid tissue—sarcoma	2.45e-05	0.0124	CbGeAlD
Phenytoin—SCN4A—Developmental Biology—HRAS—sarcoma	2.42e-05	0.000775	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—HRAS—sarcoma	2.42e-05	0.000775	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—HRAS—sarcoma	2.33e-05	0.000747	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—SRC—sarcoma	2.33e-05	0.000747	CbGpPWpGaD
Phenytoin—CYP2C19—liver—sarcoma	2.3e-05	0.0117	CbGeAlD
Phenytoin—SCN5A—Axon guidance—HRAS—sarcoma	2.3e-05	0.000736	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—VEGFA—sarcoma	2.27e-05	0.000727	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—NRAS—sarcoma	2.24e-05	0.000718	CbGpPWpGaD
Phenytoin—ALB—lymph node—sarcoma	2.19e-05	0.0111	CbGeAlD
Phenytoin—ABCB1—myometrium—sarcoma	2.16e-05	0.011	CbGeAlD
Phenytoin—CYP2C8—testis—sarcoma	2.12e-05	0.0108	CbGeAlD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.11e-05	0.000677	CbGpPWpGaD
Phenytoin—ABCB1—embryo—sarcoma	2.08e-05	0.0106	CbGeAlD
Phenytoin—ABCC2—lymph node—sarcoma	2.05e-05	0.0104	CbGeAlD
Phenytoin—SCN5A—Developmental Biology—EGFR—sarcoma	2.04e-05	0.000654	CbGpPWpGaD
Phenytoin—CYP2C8—liver—sarcoma	2.01e-05	0.0102	CbGeAlD
Phenytoin—CYP3A7—Metabolism—ENO2—sarcoma	1.99e-05	0.000639	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—HBA1—sarcoma	1.98e-05	0.000635	CbGpPWpGaD
Phenytoin—ABCB1—seminal vesicle—sarcoma	1.95e-05	0.00992	CbGeAlD
Phenytoin—SCN5A—Developmental Biology—KRAS—sarcoma	1.93e-05	0.000618	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	1.92e-05	0.000614	CbGpPWpGaD
Phenytoin—CYP2B6—testis—sarcoma	1.9e-05	0.00967	CbGeAlD
Phenytoin—ABCB1—hematopoietic system—sarcoma	1.86e-05	0.00943	CbGeAlD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.84e-05	0.00059	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.84e-05	0.000588	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.82e-05	0.000584	CbGpPWpGaD
Phenytoin—CYP3A5—liver—sarcoma	1.81e-05	0.0092	CbGeAlD
Phenytoin—CYP2B6—liver—sarcoma	1.8e-05	0.00914	CbGeAlD
Phenytoin—CYP2C9—liver—sarcoma	1.78e-05	0.00905	CbGeAlD
Phenytoin—CYP3A7—Metabolism—PLCG1—sarcoma	1.69e-05	0.000542	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	1.67e-05	0.000536	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.65e-05	0.000528	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—HRAS—sarcoma	1.64e-05	0.000525	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	1.63e-05	0.000522	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.61e-05	0.000514	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.48e-05	0.000473	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ENO2—sarcoma	1.48e-05	0.000472	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—HBA1—sarcoma	1.47e-05	0.000469	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.44e-05	0.000463	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ENO2—sarcoma	1.44e-05	0.000462	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—HBA1—sarcoma	1.43e-05	0.000459	CbGpPWpGaD
Phenytoin—ABCB1—uterus—sarcoma	1.4e-05	0.00712	CbGeAlD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.36e-05	0.000437	CbGpPWpGaD
Phenytoin—CYP3A4—liver—sarcoma	1.36e-05	0.0069	CbGeAlD
Phenytoin—ABCB1—lymphoid tissue—sarcoma	1.31e-05	0.00664	CbGeAlD
Phenytoin—CYP2B6—Metabolism—PLCG1—sarcoma	1.25e-05	0.000401	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ENO2—sarcoma	1.25e-05	0.0004	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ENO2—sarcoma	1.24e-05	0.000398	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—HBA1—sarcoma	1.24e-05	0.000397	CbGpPWpGaD
Phenytoin—ALB—Metabolism—HBA1—sarcoma	1.23e-05	0.000395	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PLCG1—sarcoma	1.22e-05	0.000392	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.21e-05	0.000388	CbGpPWpGaD
Phenytoin—ABCB1—bone marrow—sarcoma	1.19e-05	0.00605	CbGeAlD
Phenytoin—CYP2C19—Metabolism—ENO2—sarcoma	1.11e-05	0.000357	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—HBA1—sarcoma	1.11e-05	0.000355	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ENO2—sarcoma	1.09e-05	0.000348	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—HBA1—sarcoma	1.08e-05	0.000346	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PLCG1—sarcoma	1.06e-05	0.000339	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PLCG1—sarcoma	1.05e-05	0.000337	CbGpPWpGaD
Phenytoin—ABCB1—testis—sarcoma	1.02e-05	0.00517	CbGeAlD
Phenytoin—CYP2C9—Metabolism—ENO2—sarcoma	1.02e-05	0.000325	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—HBA1—sarcoma	1.01e-05	0.000323	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—IL2—sarcoma	9.89e-06	0.000317	CbGpPWpGaD
Phenytoin—ABCB1—liver—sarcoma	9.63e-06	0.00489	CbGeAlD
Phenytoin—CYP2C19—Metabolism—PLCG1—sarcoma	9.46e-06	0.000303	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PLCG1—sarcoma	9.23e-06	0.000296	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—SRC—sarcoma	8.63e-06	0.000276	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PLCG1—sarcoma	8.62e-06	0.000276	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—VEGFA—sarcoma	8.4e-06	0.000269	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—NRAS—sarcoma	8.3e-06	0.000266	CbGpPWpGaD
Phenytoin—ABCB1—lymph node—sarcoma	7.38e-06	0.00375	CbGeAlD
Phenytoin—ALB—Hemostasis—KRAS—sarcoma	7.14e-06	0.000229	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ENO2—sarcoma	6.7e-06	0.000215	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—HBA1—sarcoma	6.66e-06	0.000213	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—sarcoma	6.35e-06	0.000203	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—HRAS—sarcoma	6.07e-06	0.000194	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PLCG1—sarcoma	5.69e-06	0.000182	CbGpPWpGaD
